Dobos, A B
220  results:
Search for persons X
?
 
?
7

Effectiveness of mogamulizumab in patients with Mycosis Fun..:

Beylot‐Barry, M. ; Quereux, G. ; Nardin, C....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  9 - p. 1777-1784 , 2023
 
?
8

The COVID-19 mRNA vaccine Comirnaty induces anaphylactic sh..:

Barta, B A ; Radovits, T ; Dobos, A B...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
?
9

Effectiveness of mogamulizumab in patients with Mycosis Fun..:

Beylot-Barry, M ; Quereux, G ; Nardin, C...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jdv.19134.  , 2023
 
?
10

Effectiveness of mogamulizumab in patients with Mycosis Fun..:

Beylot-Barry, M ; Quereux, G ; Nardin, C...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jdv.19134.  , 2023
 
?
11

Effectiveness of mogamulizumab in patients with Mycosis Fun..:

Beylot-Barry, M ; Quereux, G ; Nardin, C...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jdv.19134.  , 2023
 
?
12

Effectiveness of mogamulizumab in patients with Mycosis Fun..:

Beylot-Barry, M ; Quereux, G ; Nardin, C...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jdv.19134.  , 2023
 
?
13

Effectiveness of mogamulizumab in patients with Mycosis Fun..:

Beylot-Barry, M ; Quereux, G ; Nardin, C...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jdv.19134.  , 2023
 
?
14

Effectiveness of mogamulizumab in patients with Mycosis Fun..:

Beylot-Barry, M ; Quereux, G ; Nardin, C...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jdv.19134.  , 2023
 
?
15

Effectiveness of mogamulizumab in patients with Mycosis Fun..:

Beylot-Barry, M ; Quereux, G ; Nardin, C...
info:eu-repo/semantics/altIdentifier/doi/10.1111/jdv.19134.  , 2023
 
1-15